selected scholarly activity
-
academic article
- Microbiota signatures and mucosal healing in the use of enteral nutrition therapy v. corticosteroids for the treatment of children with Crohn’s disease: a systematic review and meta-analysis. The British Journal of Nutrition: an international journal of nutritional science. 130:1385-1402. 2023
- Physical Activity in Pediatric Inflammatory Bowel Disease: A Scoping Review. Pediatric Exercise Science. 1-13. 2023
- Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada. Blood Coagulation and Fibrinolysis: international journal in haemostasis and thrombosis. 33:449-456. 2022
- Pediatric Patients With a Dual Diagnosis of Inflammatory Bowel Disease and Chronic Recurrent Multifocal Osteomyelitis: A Single-Centre Case Series - Response to Letter to the Editor. Journal of Pediatric Gastroenterology and Nutrition. 74:e129-e129. 2022
- Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease. Nutrients. 14:4-4. 2021
- Pediatric Patients with a Dual Diagnosis of Inflammatory Bowel Disease and Chronic Recurrent Multifocal Osteomyelitis. Journal of Pediatric Gastroenterology and Nutrition. 73:626-629. 2021
- Effect of Exclusive Enteral Nutrition and Corticosteroid Induction Therapy on the Gut Microbiota of Pediatric Patients with Inflammatory Bowel Disease. Nutrients. 12:1691-1691. 2020
- Barriers and Facilitators to a Good Bowel Preparation for Colonoscopy in Children: A Qualitative Study. Journal of Pediatric Gastroenterology and Nutrition. 67:188-193. 2018
- Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2018:CD000542. 2018
- Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms. Journal of Pediatric Gastroenterology and Nutrition. 56:512-518. 2013
- Determinants of quality of life in children with chronic somatic disease: pilot data from the GapS Questionnaire. Quality of Life Research. 22:339-349. 2013
- IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis. Inflammatory Bowel Diseases. 19:115-123. 2013
- Drug-induced esophageal injury with an occult vascular ring. Paediatrics and Child Health: the journal of the Canadian Paediatric Society. 16:554-556. 2011
- Assessment of knowledge in adolescents with inflammatory bowel disease using a novel transition tool. Inflammatory Bowel Diseases. 17:1131-1137. 2011
- Vulvar Inflammation as the Only Clinical Manifestation of Crohn Disease in an 8-Year-Old Girl. Pediatrics. 125:e1518-e1522. 2010
- Author's response to “Depth of inflammation in Crohn's disease”. Nature Reviews Nephrology. 5:E3-E3. 2009
- Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease. Nature Reviews Nephrology. 4:693-697. 2008
- Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study. Gastroenterology. 133:423-432. 2007
- Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews. CD000542. 2007
- Severe Colitis in Children. Journal of Pediatric Gastroenterology and Nutrition. 41:375-385. 2005
- Case 1: Abdominal pain with weight loss. Paediatrics and Child Health: the journal of the Canadian Paediatric Society. 9:719-720. 2004
- Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease. Canadian Journal of Gastroenterology and Hepatology. 18:503-508. 2004
- Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2009:CD003574. 2004
- Gastral Antral Biopsy in the Differentiation of Pediatric Colitides. American Journal of Gastroenterology. 98:557-561. 2003
- Gastral antral biopsy in the differentiation of pediatric colitides. American Journal of Gastroenterology. 98:557-561. 2003
- Pediatric Crohn Disease Activity Index: Responsive to Short-term Change. Journal of Pediatric Gastroenterology and Nutrition. 36:83-89. 2003
- Controlled Ileal Release Budesonide in Pediatric Crohn Disease: Efficacy and Effect on Growth. Journal of Pediatric Gastroenterology and Nutrition. 33:75-80. 2001
- Enteral feeding and Crohn disease. Current Opinion in Gastroenterology. 17:167-170. 2001
- Enteral nutritional therapy for induction of remission in Crohn's disease. The Clinical Respiratory Journal. CD000542. 2001
- Antineutrophil Cytoplasmic Antibodies and Anti-Saccharomyces cerevisiae Antibody: Clinical Tools or Clues for Research?. Journal of Pediatric Gastroenterology and Nutrition. 30:1-1. 2000
- Neurofibromatosis Type 1 Vasculopathy Associated With Lower Limb Hypoplasia. Pediatrics. 100:395-398. 1997
-
chapter
- Nutritional Management of Inflammatory Bowel Disease. 355-383. 2023
- Nutritional Management of Inflammatory Bowel Disease. 333-356. 2017
- Nutritional Management of Inflammatory Bowel Disease. 295-312. 2013
- Nutritional Therapy. 337-350. 2008
-
conference paper
- Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics. 645-656. 2017
- Effectiveness of Targeted Food Elimination Diet in Management of Pediatric Eosinophilic Esophagitis (EoE): A Retrospective Review.. Journal of Allergy and Clinical Immunology. AB49-AB49. 2017
- Sa2070 A Qualitative Analysis of Barriers and Facilitators to an Effective Bowel Preparation for Colonoscopy in Children. Gastrointestinal Endoscopy. AB306-AB306. 2016
- Infliximab-Induced Psoriasis in Pediatric Crohn Disease; Experience of This Paradoxical Skin Manifestation At a Tertiary Centre and a Potential Association with a Variation in the IL-23r Gene. Gastroenterology. A671-A671. 2009
- Infliximab-induced psoriasis in pediatric Crohn Disease; Experience of this paradoxical event at a tertiary centre. Inflammatory Bowel Diseases. S23-S23. 2008
- Life threatening complications of sulphasalazine therapy in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases. S21-S21. 2008
- Discontinuation of immunomodulator therapy in infliximab-treated children with Crohn disease; one year outcome evaluating influences on disease activity and infliximab antibody formation. Inflammatory Bowel Diseases. S26-S26. 2008
- The development of a valid, reliable and responsive pediatric ulcerative colitis activity index (Pucai): A prospective multicenter study. Gastroenterology. A132-A132. 2007